The Einstein Center for Epigenomics at the Albert Einstein College of Medicine in New York has entered into an agreement with CLC Bio to use the company's full suite of bioinformatics tools.
The suite includes CLC Bio's premier solutions for handling high-throughput sequencing data, CLC Genomics Workbench and CLC Genomics Server.
Dr John Greally, director of the Einstein Center for Epigenomics, said: 'CLC Bio's tools are going to put sophisticated analytical ability into the hands of molecular biologists at Einstein, and will enhance their ability to explore the massively-parallel sequencing data that we are generating.
'We see this as a way of lowering barriers for scientists who have not previously performed these high-throughput epigenomic assays, allowing them to explore their data and explore hypotheses,' he added.
